Hemolytic disease of the newborn patient with rhesus incompatibility: a case report

Main Article Content

Desak Sembah Laksmi Dewi
Ni Kadek Mulyantari
Anak Agung Wiradewi Lestari
I Nyoman Wande

Keywords

hemolytic disease of the newborn, jaundice, rhesus incompatibility

Abstract

Introduction: Hemolytic Disease of the Newborn (HDN) is characterized by hemolytic anemia and jaundice. It arises when neonates' erythrocytes coated with sensitized antibodies are destroyed. Cases of HDN are still at high risk, particularly in women and children who are incompatible with rhesus. Reporting an instance of HDN with rhesus incompatibility was the goal of this investigation.


Case description: A 2-day-old male infant came with jaundice for less than 24 hours. Complaints are accompanied by dark urination. It is a second pregnancy, patient's mother routinely had her pregnancy checked by an obstetrician. The patient's mother was given rhesus immunoglobulin medication before giving birth and after giving birth. The patient was born with sectio caesarea, did not cry immediately, birth weight 2680 grams, 37 weeks with APGAR score 5-7. The first child is a still-alive boy with no similar complaints. The patient's mother has blood type O-, the patient's father (2nd husband) has blood type AB+, and the first child from her first husband has blood type O+. Laboratory test results support HDN with rhesus incompatibility, such as reticulocytosis, normochromic normocytic anemia, anisocytosis, hyperbilirubinemia, spherocyte and fragmentocyte in peripheral blood smear, the patient has blood type B+, crossmatch incompatible, coomb’s test positive, examination of maternal rhesus antibody titer positive 1:512.


Conclusion: A 2-day-old male infant, HDN with rhesus incompatibility. Complaints, physical examination, and laboratory examinations confirmed the diagnosis. After 10 days of treatment, the patient was declared to have improved and was allowed to go home.

Abstract 625 | pdf Downloads 1280

References

1. Delaney M, Matthews DC. Hemolytic disease of the fetus and newborn: managing the mother, fetus, and newborn. Hematology. 2015;2015(1):146–51.
2. Das S, Shastry S, Chakravarthy PK, Baliga PB. Clinical Implication of Immunohaematological Tests in ABO haemolytic disease of newborn: Revisiting an old disease. Transfus Med. 2020;31(1):30–5.
3. Sihombing MR, Sari DP. Penyakit Hemolitik pada Bayi Baru Lahir. J Kedokt Meditek. 2018;24(68):73–81.
4. Koelewijn JM, Vrijkotte TGM, de Haas M, van der Schoot CE, Bonsel GJ. Risk factors for the presence of non‐rhesus D red blood cell antibodies in pregnancy. BJOG An Int J Obstet & Gynaecol. 2009;116(5):655–64.
5. Le Pichon J-B, Riordan SM, Watchko J, Shapiro SM. The Neurological Sequelae of Neonatal Hyperbilirubinemia: Definitions, Diagnosis and Treatment of the Kernicterus Spectrum Disorders (KSDs). Curr Pediatr Rev. 2017;13(3):199–209.
6. Nur A. Usia Kehamilan dan Ikterus Neonatrum. J Kesehat Marendeng. 2023;7(2):20–7.
7. Bhutani VK, Johnson L. Kernicterus in the 21st century: frequently asked questions. J Perinatol. 2009;29(S1):S20–4.
8. Dziegiel MH, Krog GR, Hansen AT, Olsen M, Lausen B, Nørgaard LN, et al. Laboratory Monitoring of Mother, Fetus, and Newborn in Hemolytic Disease of Fetus and Newborn. Transfus Med Hemother. 2021;48(5):306–15. Available from: https://pubmed.ncbi.nlm.nih.gov/34803574
9. Hall V, Vadakekut ES, Avulakunta ID. Hemolytic Disease of the Fetus and Newborn [Internet]. 2024. Available from: https://www.ncbi.nlm.nih.gov/books/NBK557423/
10. Aliviameita A. Buku Ajar Mata Kuliah Imunohematologi. Sidoarjo: Umsida Press; 2020.
11. The Calgary Guide to Understanding Disease. Hemolytic Disease of the Fetus and Newborn: Pathogenesis and Clinical Findings [Internet]. 2024. Available from: https://calgaryguide.ucalgary.ca/hemolytic-disease-of-the-fetus-and-newborn-pathogenesis-and-clinical-findings/
12. Mulyantari NK, Yasa IWPS. Laboratorium Pratransfusi Update. Udayana University Press; 2016. p. 1–150.
13. Maulida M, PS RD, Mustofa S. Hubungan Kejadian Hiperbilirubinemia dengan Inkompatibilitas ABO pada Bayi Baru Lahir di RSUD Abdul Moeloek Provinsi Lampung. Med Prof J Lampung. 2021;11(1):27–31.
14. Myle AK, Al-Khattabi GH. Hemolytic Disease of the Newborn: A Review of Current Trends and Prospects. Pediatr Heal Med Ther. 2021;12:491–8. Available from: https://pubmed.ncbi.nlm.nih.gov/34675752